{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:56:56Z","timestamp":1790499416451,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12782-y","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:01:07Z","timestamp":1790496067000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mesenchymal stem cell therapy and gut microbiota modulation in preclinical disease models: a systematic review with implications for hypertension"],"prefix":"10.1007","volume":"53","author":[{"given":"Daneesha Deivy","family":"Kumereshwaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheivanya Gayatrri","family":"Kuppusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogeswaran","family":"Lokanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arutchelvan","family":"Rajamanikam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayatri","family":"Govindaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"issue":"8","key":"12782_CR1","doi-asserted-by":"publisher","first-page":"980","DOI":"10.2174\/22123946MTE0cNjc70","volume":"16","author":"NK Farkhad","year":"2021","unstructured":"Farkhad NK, Mahmoudi A, Mahdipour E (2021) How similar are human mesenchymal stem cells derived from different origins? A review of comparative studies. Curr Stem Cell Res Ther 16(8):980\u2013993","journal-title":"Curr Stem Cell Res Ther"},{"key":"12782_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126601","author":"SY Ahn","year":"2022","unstructured":"Ahn SY, Sung DK, Chang YS, Park WS (2022) Intratracheal transplantation of mesenchymal stem cells attenuates hyperoxia\u2010induced microbial dysbiosis in the lungs, brain, and gut in newborn rats. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23126601","journal-title":"Int J Mol Sci"},{"issue":"3","key":"12782_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.36676\/urr.v11.i3.1282","volume":"11","author":"PR Chaudhary","year":"2024","unstructured":"Chaudhary PR (2024) The role of gut microbiota in health and disease: implications for therapeutic interventions. Universal Res Reports 11(3):16\u201323. https:\/\/doi.org\/10.36676\/urr.v11.i3.1282","journal-title":"Universal Res Reports"},{"key":"12782_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/nu12102982","volume":"12","author":"BJH Verhaar","year":"2020","unstructured":"Verhaar BJH, Prodan A, Nieuwdorp M, Muller M (2020) Gut microbiota in hypertension and atherosclerosis: a review. Nutrients 12:2982. https:\/\/doi.org\/10.3390\/nu12102982","journal-title":"Nutrients"},{"issue":"7","key":"12782_CR5","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1161\/CIRCRESAHA.121.318065","volume":"128","author":"EG Avery","year":"2021","unstructured":"Avery EG, Bartolomaeus H, Maifeld A, Marko L, Wiig H, Wilck N et al (2021) The gut microbiome in hypertension: recent advances and future perspectives. Circ Res 128(7):934\u2013950. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318065","journal-title":"Circ Res"},{"key":"12782_CR6","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s13238-018-0549-0","volume":"9","author":"Z Wang","year":"2018","unstructured":"Wang Z, Zhao Y (2018) Gut microbiota derived metabolites in cardiovascular health and disease. Protein Cell 9:416\u2013431. https:\/\/doi.org\/10.1007\/s13238-018-0549-0","journal-title":"Protein Cell"},{"key":"12782_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.730809","volume":"12","author":"Y Wu","year":"2021","unstructured":"Wu Y, Xu H, Tu X, Gao Z (2021) The role of short-chain fatty acids of gut microbiota origin in hypertension. Front Microbiol 12:730809","journal-title":"Front Microbiol"},{"key":"12782_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1530857","volume":"16","author":"X Huang","year":"2025","unstructured":"Huang X, Liu Y, Jiang F, Xin L, Wang Z, Hua Z et al (2025) Exploring the research progression and evolutionary trends of gut microbiome and hypertension: a bibliometric analysis. Front Microbiol 16:1530857. https:\/\/doi.org\/10.3389\/fmicb.2025.1530857","journal-title":"Front Microbiol"},{"issue":"10","key":"12782_CR9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29927","volume":"14","author":"SS Naik","year":"2022","unstructured":"Naik SS, Ramphall S, Rijal S, Prakash V, Ekladios H, Mulayamkuzhiyil Saju J et al (2022) Association of gut microbial dysbiosis and hypertension: a systematic review. Cureus 14(10):e29927. https:\/\/doi.org\/10.7759\/cureus.29927","journal-title":"Cureus"},{"key":"12782_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-022-00526-0","volume":"28","author":"W Wang","year":"2022","unstructured":"Wang W, Wang Y, Chi J, Tan X, Hu J, Ma X et al (2022) hUCMSCs carrying exenatide prevent T1DM by improving intestinal microflora composition and islet tissue damage repair. Mol Med 28:155. https:\/\/doi.org\/10.1186\/s10020-022-00526-0","journal-title":"Mol Med"},{"issue":"2","key":"12782_CR11","doi-asserted-by":"publisher","first-page":"189.e1","DOI":"10.1016\/j.jtct.2023.11.005","volume":"30","author":"X Bu","year":"2024","unstructured":"Bu X, Gao Y, Pan W, Liu L, Wang J, Yin Z et al (2024) Human amniotic membrane-derived mesenchymal stem cells prevent acute graft-versus-host disease in an intestinal microbiome-dependent manner. Transplant Cell Ther 30(2):189.e1-189.e13","journal-title":"Transplant Cell Ther"},{"key":"12782_CR12","doi-asserted-by":"crossref","unstructured":"Bu X, Pan W, Wang J, Liu L, Yin Z, Jin H, et al (2023) Therapeutic Effects of HLA-G5 Overexpressing hAMSCs on aGVHD After Allo-HSCT: Involving in the Gut Microbiota at the Intestinal Barrier. J Inflamm Res 16:3669\u201385. https:\/\/pubmed.ncbi.nlm.nih.gov\/37645691\/","DOI":"10.2147\/JIR.S420747"},{"issue":"5","key":"12782_CR13","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1007\/s12015-023-10522-4","volume":"19","author":"X Bu","year":"2023","unstructured":"Bu X, Wang J, Yin Z, Pan W, Liu L, Jin H et al (2023) Human amniotic mesenchymal stem cells alleviate aGVHD after allo-HSCT by regulating interactions between gut microbiota and intestinal immunity. Stem Cell Rev Rep 19(5):1370\u20131383","journal-title":"Stem Cell Rev Rep"},{"key":"12782_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122189","author":"Y Fu","year":"2023","unstructured":"Fu Y, Zhang C, Xie H, Wu Z, Tao Y, Wang Z et al (2023) Human umbilical cord mesenchymal stem cells alleviated TNBS-induced colitis in mice by restoring the balance of intestinal microbes and immunoregulation. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2023.122189","journal-title":"Life Sci"},{"key":"12782_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.642948","author":"R He","year":"2021","unstructured":"He R, Han C, Li Y, Qian W, Hou X (2021) Cancer-preventive role of bone marrow-derived mesenchymal stem cells on colitis-associated colorectal cancer: roles of gut microbiota involved. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2021.642948","journal-title":"Front Cell Dev Biol"},{"key":"12782_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1243102","author":"F Hua","year":"2023","unstructured":"Hua F, Cui E, Lv L, Wang B, Li L, Lu H et al (2023) Fecal microbiota transplantation from HUC-MSC-treated mice alleviates acute lung injury in mice through anti-inflammation and gut microbiota modulation. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2023.1243102","journal-title":"Front Microbiol"},{"key":"12782_CR17","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00213-021-06037-w","volume":"239","author":"R Jiang","year":"2022","unstructured":"Jiang R, Wang Y, Liu J, Wu Z, Wang D, Deng Q et al (2022) Gut microbiota is involved in the antidepressant effects of adipose-derived mesenchymal stem cells in chronic social defeat stress mouse model. Psychopharmacology 239:533\u2013549. https:\/\/doi.org\/10.1007\/s00213-021-06037-w","journal-title":"Psychopharmacology"},{"key":"12782_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122330","volume":"336","author":"J Li","year":"2024","unstructured":"Li J, Lin W, Yuan C, Zhang L, Ji Q, Xu A et al (2024) Intravenous transplantation of bone marrow-derived mesenchymal stem cells improved behavioral deficits and altered fecal microbiota composition of BTBR mice. Life Sci 336:122330. https:\/\/doi.org\/10.1016\/j.lfs.2023.122330","journal-title":"Life Sci"},{"key":"12782_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-023-03471-9","author":"A Liu","year":"2023","unstructured":"Liu A, Liang X, Wang W, Wang C, Song J, Guo J et al (2023) Human umbilical cord mesenchymal stem cells ameliorate colon inflammation via modulation of gut microbiota-SCFAs-immune axis. Stem Cell Res Ther. https:\/\/doi.org\/10.1186\/s13287-023-03471-9","journal-title":"Stem Cell Res Ther"},{"key":"12782_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.960208","volume":"12","author":"A Liu","year":"2022","unstructured":"Liu A, Wang X, Liang X, Wang W, Li C, Qian J et al (2022) Human umbilical cord mesenchymal stem cells regulate immunoglobulin a secretion and remodel the diversification of intestinal microbiota to improve colitis. Front Cell Infect Microbiol 12:960208. https:\/\/doi.org\/10.3389\/fcimb.2022.960208","journal-title":"Front Cell Infect Microbiol"},{"key":"12782_CR21","doi-asserted-by":"crossref","unstructured":"Liu S, Wang T, Liu Y, Li Y, Ma J, Hu Q, et al (2025) Human placental mesenchymal stem cells ameliorates premature ovarian insufficiency by modulating gut microbiota and suppressing the inflammation in rats. PLoS One 20(3 March). https:\/\/pubmed.ncbi.nlm.nih.gov\/40043087\/","DOI":"10.1371\/journal.pone.0313763"},{"key":"12782_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.712139","volume":"12","author":"L Luo","year":"2021","unstructured":"Luo L, Chen Q, Yang L, Zhang Z, Xu J, Gou D (2021) MSCs therapy reverse the gut microbiota in hypoxia-induced pulmonary hypertension mice. Front Physiol 12:712139","journal-title":"Front Physiol"},{"key":"12782_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0313989","author":"Y Luo","year":"2025","unstructured":"Luo Y, Zhou S, Zhang X, Lin Y, Liu J, Cheng W et al (2025) The role of the microbiota and metabolites in the treatment of pulmonary fibrosis with UC-MSCs: integrating fecal metabolomics and 16S rDNA analysis. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0313989","journal-title":"PLoS ONE"},{"key":"12782_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-020-01902-5","author":"J Sun","year":"2020","unstructured":"Sun J, Ding X, Liu S, Duan X, Liang H, Sun T (2020) Adipose-derived mesenchymal stem cells attenuate acute lung injury and improve the gut microbiota in septic rats. Stem Cell Res Ther. https:\/\/doi.org\/10.1186\/s13287-020-01902-5","journal-title":"Stem Cell Res Ther"},{"key":"12782_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.808905","author":"Z Sun","year":"2022","unstructured":"Sun Z, Gu P, Xu H, Zhao W, Zhou Y, Zhou L et al (2022) Human umbilical cord mesenchymal stem cells improve locomotor function in Parkinson\u2019s disease mouse model through regulating intestinal microorganisms. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2021.808905","journal-title":"Front Cell Dev Biol"},{"key":"12782_CR26","doi-asserted-by":"crossref","unstructured":"Tan X, Wang D, Lu P, Guan S, Zheng Q, Du X, et al (2023) Bone marrow mesenchymal stem cells alleviate stress-induced hyperalgesia by restoring gut microbiota and inhibiting neuroinflammation in the spinal cord by targeting the AMPK\/NF-\u03baB signalling pathway. Life Sci 314:121318. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0024320522010189?via%3Dihub","DOI":"10.1016\/j.lfs.2022.121318"},{"key":"12782_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122502","author":"M Thandar","year":"2024","unstructured":"Thandar M, Yang X, Zhu Y, Zhang X, Chen Z, Huang S et al (2024) Dysbiosis of gut microbiota and metabolites is associated with radiation-induced colorectal fibrosis and is restored by adipose-derived mesenchymal stem cell therapy. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2024.122502","journal-title":"Life Sci"},{"key":"12782_CR28","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.2147\/JIR.S402592","volume":"16","author":"H Wang","year":"2023","unstructured":"Wang H, Sun Y, Xiao FJ, Zhao X, Zhang WY, Xia YJ, Wang LS (2023) Mesenchymal stem cells ameliorate DSS-induced experimental colitis by modulating the gut microbiota and MUC-1 pathway. J Inflamm Res 16:2023\u20132039. https:\/\/doi.org\/10.2147\/JIR.S402592","journal-title":"J Inflamm Res"},{"key":"12782_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05486-z","author":"L Wang","year":"2024","unstructured":"Wang L, Deng Z, Li Y, Wu Y, Yao R, Cao Y et al (2024) Ameliorative effects of mesenchymal stromal cells on senescence associated phenotypes in naturally aged rats. J Transl Med. https:\/\/doi.org\/10.1186\/s12967-024-05486-z","journal-title":"J Transl Med"},{"key":"12782_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-04038-y","author":"Q Xie","year":"2024","unstructured":"Xie Q, Gong S, Cao J, Li A, Kulyar MF, Wang B et al (2024) Mesenchymal stem cells: a novel therapeutic approach for feline inflammatory bowel disease. Stem Cell Res Ther. https:\/\/doi.org\/10.1186\/s13287-024-04038-y","journal-title":"Stem Cell Res Ther"},{"key":"12782_CR31","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.bbi.2024.08.047","volume":"122","author":"C Xing","year":"2024","unstructured":"Xing C, Zhang X, Wang D, Chen H, Gao X, Sun C et al (2024) Neuroprotective effects of mesenchymal stromal cells in mouse models of Alzheimer\u2019s disease: the mediating role of gut microbes and their metabolites via the Microbiome-Gut-Brain axis. Brain Behav Immun 122:510\u2013526","journal-title":"Brain Behav Immun"},{"key":"12782_CR32","doi-asserted-by":"crossref","unstructured":"Xu Y, Zha H, Chen W, Cao H, Li L (2020) Recovery Dynamics of Intestinal Bacterial Communities of CCl4-Treated Mice with or without Mesenchymal Stem Cell Transplantation over Different Time Points. Biomed Res Int 2020. https:\/\/pubmed.ncbi.nlm.nih.gov\/33123564\/","DOI":"10.1155\/2020\/1673602"},{"key":"12782_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-022-03118-1","author":"F Yang","year":"2022","unstructured":"Yang F, Ni B, Liu Q, He F, Li L, Zhong X et al (2022) Human umbilical cord-derived mesenchymal stem cells ameliorate experimental colitis by normalizing the gut microbiota. Stem Cell Res Ther. https:\/\/doi.org\/10.1186\/s13287-022-03118-1","journal-title":"Stem Cell Res Ther"},{"issue":"21","key":"12782_CR34","doi-asserted-by":"publisher","first-page":"21660","DOI":"10.18632\/aging.103962","volume":"12","author":"Z Yang","year":"2020","unstructured":"Yang Z, Xia Q, Lu D, Yue H, Zhang J, Li Y et al (2020) Human mesenchymal stem cells treatment improved hepatic lesions and reversed gut microbiome disorder in nonalcoholic steatohepatitis. Aging (Albany NY) 12(21):21660\u201321673","journal-title":"Aging (Albany NY)"},{"key":"12782_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.905567","author":"M Yuan","year":"2022","unstructured":"Yuan M, Lin L, Cao H, Zheng W, Wu L, Zuo H et al (2022) Intestinal microbiota participates in the protective effect of HO-1\/BMMSCs on liver transplantation with steatotic liver grafts in rats. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2022.905567","journal-title":"Front Microbiol"},{"issue":"12","key":"12782_CR36","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.4252\/wjsc.v13.i12.1905","volume":"13","author":"LN Zhao","year":"2021","unstructured":"Zhao LN, Ma SW, Xiao J, Yang LJ, Xu SX, Zhao L (2021) Bone marrow mesenchymal stem cell therapy regulates gut microbiota to improve poststroke neurological function recovery in rats. World J Stem Cells 13(12):1905\u20131917","journal-title":"World J Stem Cells"},{"key":"12782_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116033","author":"SJ Zheng","year":"2024","unstructured":"Zheng SJ, Luo Y, Wang JB, Chen XM, Xu Y, Xiao JH (2024) Regulated intestinal microbiota and gut immunity to ameliorate type 1 diabetes mellitus: a novel mechanism for stem cell-based therapy. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2023.116033","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"12782_CR38","doi-asserted-by":"publisher","first-page":"152.e1","DOI":"10.1016\/j.jtct.2020.10.013","volume":"27","author":"S Zhu","year":"2021","unstructured":"Zhu S, Li H, Lv C, Liang J, Liu L, Zhang X et al (2021) Combination of mesenchymal stem cell and endothelial progenitor cell infusion accelerates injured intestinal repair by regulating gut microbiota after hematopoietic cell transplantation. Transplant Cell Ther 27(2):152.e1-152.e9","journal-title":"Transplant Cell Ther"},{"key":"12782_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1139","author":"Y Zou","year":"2024","unstructured":"Zou Y, Xiao W, Liu D, Li X, Li L, Peng L et al (2024) Human umbilical cord mesenchymal stem cells improve disease characterization of Sjogren\u2019s syndrome in NOD mice through regulation of gut microbiota and Treg\/Th17 cellular immunity. Immunity Inflamm Dis. https:\/\/doi.org\/10.1002\/iid3.1139","journal-title":"Immunity Inflamm Dis"},{"key":"12782_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ph17050607","volume":"17","author":"Y Qiao","year":"2024","unstructured":"Qiao Y, Tang X, Liu Z, Ocansey DKW, Zhou M, Shang A et al (2024) Therapeutic prospects of mesenchymal stem cells and their derived exosomes in the regulation of the gut microbiota in inflammatory bowel disease. Pharmaceuticals (Basel) 17:607. https:\/\/doi.org\/10.3390\/ph17050607","journal-title":"Pharmaceuticals (Basel)"},{"key":"12782_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.594150","volume":"11","author":"S Mohammad","year":"2021","unstructured":"Mohammad S, Thiemermann C (2021) Role of metabolic endotoxemia in systemic inflammation and potential interventions. Front Immunol 11:594150","journal-title":"Front Immunol"},{"key":"12782_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126242","volume":"22","author":"M Candelli","year":"2021","unstructured":"Candelli M, Franza L, Pignataro G, Ojetti V, Covino M, Piccioni A et al (2021) Interaction between lipopolysaccharide and gut microbiota in inflammatory bowel diseases. Int J Mol Sci 22:6242. https:\/\/doi.org\/10.3390\/ijms22126242","journal-title":"Int J Mol Sci"},{"key":"12782_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.900381","volume":"9","author":"Y Lu","year":"2022","unstructured":"Lu Y, Zhang Y, Zhao X, Shang C, Xiang M, Li L et al (2022) Microbiota-derived short-chain fatty acids: implications for cardiovascular and metabolic disease. Front Cardiovasc Med 9:900381. https:\/\/doi.org\/10.3389\/fcvm.2022.900381","journal-title":"Front Cardiovasc Med"},{"key":"12782_CR44","doi-asserted-by":"crossref","unstructured":"Guo Y, Li X, Wang Z, Yu B (2021) Gut Microbiota Dysbiosis in Human Hypertension: A Systematic Review of Observational Studies. Front Cardiovasc Med 8:650227. https:\/\/www.frontiersin.org","DOI":"10.3389\/fcvm.2021.650227"},{"issue":"5","key":"12782_CR45","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1007\/s12015-023-10539-9","volume":"19","author":"G Yang","year":"2023","unstructured":"Yang G, Fan X, Liu Y, Jie P, Mazhar M, Liu Y et al (2023) Immunomodulatory mechanisms and therapeutic potential of mesenchymal stem cells. Stem Cell Rev Rep 19(5):1214\u20131231","journal-title":"Stem Cell Rev Rep"},{"issue":"12","key":"12782_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7120583","volume":"7","author":"H Cheng","year":"2019","unstructured":"Cheng H, Guan X, Chen D, Ma W (2019) The Th17\/Treg cell balance: a gut microbiota-modulated story. Microorganisms 7(12):583","journal-title":"Microorganisms"},{"issue":"12","key":"12782_CR47","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/jch.14722","volume":"25","author":"M Cai","year":"2023","unstructured":"Cai M, Lin L, Jiang F, Peng Y, Li S, Chen L et al (2023) Gut microbiota changes in patients with hypertension: a systematic review and meta-analysis. J Clin Hypertens 25(12):1053\u20131068. https:\/\/doi.org\/10.1111\/jch.14722","journal-title":"J Clin Hypertens"},{"key":"12782_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-016-0222-x","author":"J Li","year":"2017","unstructured":"Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G et al (2017) Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. https:\/\/doi.org\/10.1186\/s40168-016-0222-x","journal-title":"Microbiome"},{"issue":"1","key":"12782_CR49","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s44161-022-00197-4","volume":"2","author":"HA Jama","year":"2023","unstructured":"Jama HA, Rhys-Jones D, Nakai M, Yao CK, Climie RE, Sata Y et al (2023) Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial. Nat Cardiovasc Res 2(1):35\u201343","journal-title":"Nat Cardiovasc Res"},{"issue":"13","key":"12782_CR50","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.024763","volume":"11","author":"C Tilves","year":"2022","unstructured":"Tilves C, Yeh HC, Maruthur N, Juraschek SP, Miller E, White K et al (2022) Increases in circulating and fecal butyrate are associated with reduced blood pressure and hypertension: results from the SPIRIT trial. J Am Heart Assoc 11(13):e024763. https:\/\/doi.org\/10.1161\/JAHA.121.024763","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"12782_CR51","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/jcp.25435","volume":"232","author":"A Bein","year":"2017","unstructured":"Bein A, Zilbershtein A, Golosovsky M, Davidov D, Schwartz B (2017) LPS induces hyper-permeability of intestinal epithelial cells. J Cell Physiol 232(2):381\u2013390","journal-title":"J Cell Physiol"},{"issue":"1","key":"12782_CR52","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41569-022-00737-2","volume":"20","author":"F Violi","year":"2022","unstructured":"Violi F, Cammisotto V, Bartimoccia S, Pignatelli P, Carnevale R, Nocella C (2022) Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease. Nat Rev Cardiol 20(1):24\u201337","journal-title":"Nat Rev Cardiol"},{"key":"12782_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.648472","author":"P Jayaraman","year":"2021","unstructured":"Jayaraman P, Lim R, Ng J, Vemuri MC (2021) Acceleration of translational mesenchymal stromal cell therapy through consistent quality GMP manufacturing. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2021.648472","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"12782_CR54","doi-asserted-by":"publisher","first-page":"73","DOI":"10.21037\/atm-23-1936","volume":"12","author":"KS Seow","year":"2024","unstructured":"Seow KS, Ling APK (2024) Mesenchymal stem cells as future treatment for cardiovascular regeneration and its challenges. Ann Transl Med 12(4):73\u201373","journal-title":"Ann Transl Med"},{"issue":"1","key":"12782_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-023-03589-w","volume":"14","author":"JC Fitzgerald","year":"2023","unstructured":"Fitzgerald JC, Shaw G, Murphy JM, Barry F (2023) Media matters: culture medium-dependent hypervariable phenotype of mesenchymal stromal cells. Stem Cell Res Ther 14(1):1\u201318","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"12782_CR56","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1097\/HJH.0000000000003423","volume":"41","author":"S Chakraborty","year":"2023","unstructured":"Chakraborty S, Lulla A, Cheng X, Yeo JY, Mandal J, Yang T et al (2023) Conjugated bile acids are nutritionally reprogrammable antihypertensive metabolites. J Hypertens 41(6):979\u2013994","journal-title":"J Hypertens"},{"issue":"11","key":"12782_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119192","volume":"24","author":"G Baranwal","year":"2023","unstructured":"Baranwal G, Goodlett BL, Arenaz CM, Creed HA, Navaneethabalakrishnan S, Rutkowski JM et al (2023) Indole propionic acid increases T regulatory cells and decreases T helper 17 cells and blood pressure in mice with salt-sensitive hypertension. Int J Mol Sci 24(11):9192","journal-title":"Int J Mol Sci"},{"key":"12782_CR58","unstructured":"Araujo A de, Kumar HS, Yang T, Plata AA, Dirr EW, Bearss N, et al (2024) Intestinal serotonergic vagal signalling as a mediator of microbiota-induced hypertension. bioRxiv 2024.07.17.603451. https:\/\/www.biorxiv.org\/content\/10.1101\/2024.07.17.603451v2"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12782-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12782-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12782-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:01:10Z","timestamp":1790496070000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12782-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12782"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12782-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]},"assertion":[{"value":"30 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No potential conflicts of interest were disclosed.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This systematic review analyzed previously published animal studies; no new ethical approval was required.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1632"}}